Barbara Buldini

11PUBLICATIONS
167CO-AUTHORS
AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Jun 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

Pageof 2